RYAH Group Inc. RYAH Archives - Page 2 of 6

ThursdayDec 16, 2021 10:53 am

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) to Collaborate with OMNI Medical Services for Cannabis Study in Treatment of COVID-19

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has announced plans for a U.S. clinical study focused on treatment COVID-19. RYAH will be partnering with OMNI Medical Services to perform the U.S.-based clinical study evaluating patients using inhalation of medical cannabis to both treat and prevent the coronavirus. The study, which will run for five years, will involve the use of RYAH’s Smart Inhaler devices and will involve up to 11,000 of OMNI’s patients across the country. Phase 2 of the…

MondayDec 13, 2021 12:51 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Unearthing Breakthrough Discoveries That Will Reshape Understanding of Plant-Based Medicines

RYAH Group (CSE: RYAH) is a leading data technology company in plant-based medicine committed to providing valuable insight and transforming patient care through big data and artificial intelligence. According to a recent article, which contains excerpts from a RYAH blog post, “The company is working to unearth breakthrough discoveries that will reshape the understanding of plant-based medicines.” In the blog post, for instance, RYAH provided an overview of the United Kingdom’s legal cannabis market, observing that “market analysts continue to place high hopes on the potential of the U.K. market. Yet, in its current form, there remains significant room for…

WednesdayDec 08, 2021 3:48 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Medical Device Certification for IoT-Powered Dry Herb Inhaler, Software

RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received ISO 13485:2016/MDSAP and EN ISO 13485:2016 certification for its proprietary Internet of Things (“IoT”)-powered dry herb inhaler (the “RYAH Smart Inhaler”) and software application associated with the device. According to the update, the certification is a regulatory requirement and an international standard that outlines the requirements for a quality management system specific to the medical devices industry. “This is a monumental achievement for RYAH Group Inc. and its subsidiary, RYAH Medtech Inc., as we continue to reimagine plant-based medicine delivery solutions for doctors, clinics and their…

TuesdayDec 07, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) to Deliver Solutions for Clinicians Examining Cannabis Efficacy in Cancer Treatment

Multiple ongoing studies are researching the relationship between medical cannabis and cancer treatment The viability of clinical studies within the sector is hampered by lack of exact measurement of a patient’s intake RYAH Group intends to resolve this issue with the launch of it’s proprietary RYAH Smart Dry Herb Inhaler The company successfully delivered on its first Inhaler order in May 2021, and announced that they had received a follow-on order in November 2021 In 1980, The United States National Cancer Institute (“NCI”) began experimental distribution of a novel drug called Marinol, an oral form of THC (the primary active…

MondayNov 29, 2021 12:13 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces Refiling of Amended, Restated MD&A and Financial Statements

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has amended, restated and refiled information covering the three and six months ended June 30, 2021. Information refiled includes RYAH’s management discussion and analysis (“MD&A”) and condensed, consolidated interim financial statements for the six months ended June 30, 2021. The MD&A material includes information regarding the company's operations, business objectives, and relationships with third parties as well as marketing expenditures incurred during the three- and six-month period ended June 30, 2021. The material…

MondayNov 29, 2021 9:30 am

RYAH Group Inc. (CSE: RYAH) Releases Overview of UK Cannabis Market

Market analysts place high hopes on the potential of the United Kingdom market Growing demand from patients and patient families brought the country’s medical cannabis program to a tipping point RYAH is committed to providing valuable insight and transforming patient care through big data and artificial intelligence After three years of medical cannabis being legal in the United Kingdom, the country has a total of only three patients with a prescription in the entire public system, noted a recent blog from RYAH Group (CSE: RYAH). The article noted that many more patients receive cannabis-derived medications, including flower and cannabis oil,…

MondayNov 15, 2021 1:02 pm

QualityStocksNewsBreaks– RYAH Group Inc. (CSE: RYAH) Signs LOI to Develop Delivery Solutions for Psychoactive Compounds

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, is partnering with Emotional Intelligence Ventures (Ei.Ventures), a leading psychedelic formulation and therapeutic research company. The collaboration is designed to evaluate the compatibility of RYAH’s proprietary Smart Patch delivery and monitoring device, software and data platform with Ei.Ventures’ proprietary psychedelic formulations. In addition, the two companies will work together on advancing Ei.Ventures’ research and development strategy. The partnership takes the two companies a step closer to negotiating and finalizing certain definitive research and…

MondayNov 08, 2021 2:47 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Receives Additional Order as Its Ecosystem Continues to Power Trials, Pilots and Studies in Plant-Based Medicine

RYAH Group (CSE: RYAH) today announced its receipt of an additional order for future shipments of hundreds of its proprietary RYAH Smart Dry Herb Inhalers and accessories to its United Kingdom-based industry partner, an international clinic undertaking one of the world’s largest and most comprehensive clinical trials in plant-based medicine. The order follows the recently announced initial shipment, and the devices will be used by a growing number of participants of the major U.K.-based clinical trial. Over the next five years, the trial is planned to engage tens of thousands of United Kingdom patients and aims to focus on studying the…

FridayNov 05, 2021 10:39 am

German Cannabis Market Expected to Liberalize Post Election, RYAH Group Inc. (CSE: RYAH) Enters Germany Via Observational Study

German Social Democrat-led coalition expected to liberalize medical cannabis market Analysts predict over one million medical cannabis patients in Germany by 2024, market estimated to reach $8.9 billion by 2028 RYAH entered German market via observational study with Four 20 Pharma GmbH RYAH provides IoT product ecosystem of volume-control devices, medicine-carrying components, mobile applications RYAH ecosystem offers reliable way for researchers and clinicians to develop well-controlled research environments Germany’s recent 2021 election is expected to result in a new political environment via a coalition containing cannabis-positive political factions that aim to liberalize the country’s plant-based medicine market (https://ibn.fm/t1Zgg). RYAH Group…

TuesdayOct 26, 2021 2:28 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Enters LOI to Acquire Omni Services LLC

RYAH Group (CSE: RYAH) today announced its entry into a non-binding letter of intent (“LOI”) with Omni Services LLC (d/b/a “Omni Medical Services” or “Omni”), a leading physician-owned and operated telehealth, cannabis clinic and certifications company operating in the United States, with respect to the potential acquisition of 100% of the business and assets of Omni. The LOI, if consummated, is expected to combine Omni's clinical research capabilities with the company's IoT monitoring and control devices, and further the company's ability to procure state and federal grants in the United States, which are reserved for the funding of clinical research…

Site Search

Company Search

Tag: RYAH Group Inc. RYAH